James Robert Christopher Mathieson

James’ experience includes advising:

• Meta in its acquisition of GIPHY and related UK litigation before the Competition Appeal Tribunal and Court of Appeal
• Thermo Fisher Scientific on merger control aspects of its acquisition of Olink, a leading provider of next-generation proteomics solutions, including an unconditional clearance by the UK CMA
• Bunge Limited on merger control and FDI aspects of its US$34 billion merger with Viterra
• Viasat FDI and merger control aspects of its planned US$7.3 billion acquisition of Inmarsat, including an unconditional clearance by the UK CMA
• Fedrigoni in its acquisition of Arjowiggins’ Spanish subsidiary, Guarro Casas
• Saur on merger control aspects of its acquisition of Veolia’s divested MWS business
• Shift4, a leading provider of integrated payment and technology solutions, on merger control aspects of its US$575 million acquisition of Finaro
• Epiris on merger control aspects of its acquisition of Inchcape Shipping Services (ISS)
• NVIDIA in its US$40 billion planned acquisition of Arm, and its planned acquisition of Run:ai
• Agility on foreign direct investment aspects of its £571 million acquisition of John Menzies
• One Rock Capital Partners on foreign direct investment aspects of its acquisition of Therm-O-Disc business of Emerson
• A private equity firm on foreign direct investment aspects of its acquisition of a stake in Wayve
• B-Flexion, a private investment firm, on antitrust and foreign direct investment control aspects of its sale of Affidea Group
• Tyman plc in relation to its sale to Quanex
• Darktrace in its US$5.3 billion take-private acquisition by Thoma Bravo
• Cadence Inc in its acquisitions of Pulsic Limited and BETA CAE